Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2009 |
| End Date: | June 2012 |
Randomized Phase II Study of Omega-3-Fatty Acid on Joint Symptoms Induced by Aromatase Inhibitors in Breast Cancer Patients
There are no data regarding the use of supplements to alleviate the musculoskeletal pain and
stiffness inducted by the use of aromatase inhibitors. This study is designated to test the
safety and efficacy of omega 3 fatty acid supplementation to alleviate musculoskeletal pain
in postmenopausal breast cancer patients.
There are no data regarding the use of these supplements in other types of musculoskeletal
pain and discomfort, namely AI induced joint pain and joint stiffness. Given the lack of
effective treatments for AI induced joint pain/ stiffness and the safety and efficacy of
omega 3 fatty acid for musculoskeletal pain, it is therefore reasonable to test the efficacy
of these dietary supplements in a population of postmenopausal breast cancer patients who
experience joint pain related to aromatase inhibitors. Since women with hormone receptor
positive breast cancer require long term hormonal therapy, an important objective is
minimizing long term side effects to enhance patient compliance and improve quality of life.
We found this trial at
1
site
Columbia Presbyterian Med Ctr On January 1, 1998, The New York Hospital publicly announced its...
Click here to add this to my saved trials
